Certain psychiatric medications are marketed in the United States for indications other than their primary psychiatric use. In such situations, the drug is often sold under a different brand name. There are, no doubt, good marketing reasons for doing so. But this leads to a potential problem. The patient may be taking a psychiatric medication but…